Abstract
Materials and methods MTCT rates among patients receiving antenatal HAART at our institution were evaluated and compared to MTCT rates among women identified as HIV-1 infected late in pregnancy including women who became HIV-1 seropositive during gestation. Rapid HIV testing of pregnant women was performed on all women admitted in labor to our institution who had negative HIV results > 3 months prior or with unknown HIV-1 serostatus. Neonatal infection was ascertained using RNA and DNA PCR at several time points.
Highlights
Mother to Child HIV-1 Transmission (MTCT) is infrequent among women who receive highly active antiretroviral therapy (HAART) throughout pregnancy [1]
MTCT rates among patients receiving antenatal HAART at our institution were evaluated and compared to MTCT rates among women identified as HIV-1 infected late in pregnancy including women who became HIV-1 seropositive during gestation
Rapid HIV testing of pregnant women was performed on all women admitted in labor to our institution who had negative HIV results > 3 months prior or with unknown HIV-1 serostatus
Summary
Mother to Child HIV-1 Transmission (MTCT) is infrequent among women who receive highly active antiretroviral therapy (HAART) throughout pregnancy [1]. Women who undergo primary HIV-1 infection during pregnancy, are at high risk of perinatal transmission [2]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
